Table 4.
Multivariate regression analysis of both Fentanyl > 50 mcg and Midazolam > 3 mg
| Variable for Fentanyl > 50 mcg and midazolam > 3 mg | Coefficient | P value | OR (95%CI) |
| Age | -0.04 | < 0.0001 | 0.95 (0.94-0.95) |
| Indication for endoscopy (reference - screening) | |||
| Bleeding | -0.11 | 0.18 | 0.89 (0.76-1.05) |
| Abdominal pain | 0.37 | 0.01 | 1.45 (1.08-1.96) |
| Change in BM | 0.13 | 0.18 | 1.14 (0.93-1.40) |
| IBD | 0.37 | 0.02 | 1.45 (1.04-2.032) |
| Intraprocedural characteristics | |||
| Difficult procedure | 0.55 | < 0.0001 | 1.73 (1.48-2.03) |
| Interventions | 0.1 | 0.12 | 1.10 (0.97-1.25) |
| Past history | |||
| Abdominal surgery | 0.30 | < 0.0001 | 1.33 (1.17-1.52) |
| Colonoscopy | 0.33 | 0.0001 | 1.39 (1.21-1.60) |
| Medication/substance use | |||
| Opioids | 0.41 | 0.46 | 0.49 (0.07-3.36) |
| Benzodazepines | 0.36 | 0.36 | 3.76 (0.21-64) |
| Antidepressants | 0.22 | 0.6 | 0.48 (0.03-7.76) |
| Alcohol | 0.23 | 0.02 | 1.26 (1.03-1.54) |
BM: Bowel movements; IBD: Inflammatory bowel disease.